MedTrace Logo

Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use

NCT01200849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2014-11-18

No results posted yet for this study

Summary

The overall objective of this study is to test the efficacy of an evidence-based, enhanced Rx container label design to improve Spanish speaking patients' understanding of instructions for use.

Conditions

Interventions

OTHER

Enhanced Label

A prescription drug label that has simplified text, more white space and overall is more patient-friendly.

Sponsors & Collaborators

Principal Investigators

  • Michael Wolf, Phd, MPH · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200849 on ClinicalTrials.gov